Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)
Titel:
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)
Auteur:
Loibl, Sibylle Mueller, Volkmar Minckwitz, Gunter von Conrad, Bettina Koehne, Claus-Henning Kremers, Stephan Forstbauer, Helmut Linder, Mattea Nekljudova, Valentina Moebus, Volker